"Sildenafil is not for all”

LIF was present in the media  The topic of the week was “The sildenafil”.
Sildenafil is the drug commonly known for its commercial brand: Viagra.
Many mass media gave the information as “Santa Fe delivered Viagra for all”.
The media use the name “Viagra” because this brand was the first to appear in the commercial market of medicines. It is the drug used to treat erectile dysfunction. This pathology commonly appears in patients with diabetes and hypertension.
Our concept about this topic is different.
We at LIF say: “Sildenafil is not for all” because this medication will be delivered to the patients via a recipe and under medical control and supervision.
We consider that the expression “Viagra for all” may be used today because  exists a massive but incorrect use of Sildenafil. LIF proposes of a rational use.

Nowadays there is a recreational use by young adults although a lot of them don’t need this drug.

LIF delivered antibiotics to Concordia

On Wednesday, August 29 LIF provided 200.000 tablets of Amoxicillin 500 mg and 100.000 tablets of Cefalexin 500 mg to Concordia Town Hall.

LIF had already participated in the latest bid announced by Health Secretary of Concordia to buy different medicines. On this occasion, Santa Fe’s Laboratory had the best price for these two Beta-lactam tablets.

LIF’s main objective is to provide its medicines for primary healthcare in Santa Fe but for the past four years the Laboratory has provided medicines to other provinces (Misiones, Formosa and Río Negro), city governments (Bahía Blanca and Mar del Plata in the province of Buenos Aires; Concordia in Entre Ríos province) and REMEDIAR Program of the National Health Ministry.

LIF GOT 2012 RESEARCH GRANT

As in 2011, LIF got a research grant from the National Ministry of Health.
This grant is part of the Research Program “Ramón Carrillo – Arturo Oñativia” and it will be applied to research into different health topics.

On Friday, June 1, Engineer José Berardo (Planning Manager) attended the Medicine National Academy to receive the grant.

Such grants are an incentive for Argentine professionals to research in health and are delivered every year by the National Committee “Salud Investiga”.


LIF will focus research on: What is a doctor's opinion in Santa Fe as regards the public production of medicines ?



Antecedent: 2011 Research Grant
http://lifnews.blogspot.com.ar/2011/07/lif-got-research-grant.html

IMPORTANT AGREEMENT BETWEEN LIF AND PHARMACISTS’ COLLEGE

On May 22, LIF SE’s Directors Diego Bruno and Guillermo Cleti signed an important agreement of “Mutual collaboration and internship”.

The meeting took place at the Pharmacists’ College where LIF SE’s Directors met with the main authorities Damián Sudano (President), Alicia Caraballo (Vice-President), Claudio Morales (Secretary), and Adriana Cuello (Treasurer).

The main objective is to provide mutual assistance in pharmaceutical industrial education.  

The pharmacist intern is a graduate who is selected by LIF and College jointly for the purpose of gaining instruction and experience in the practice of pharmaceutical industry. This part time practice at LIF SE is part of a nine- month pedagogic program under the supervision and evaluation of both institutions.

LIF will deliver Paracetamol to the National Government

        On April 24, LIF will finish the provision of 9.500.000 Paracetamol 500 mg tablets to the national program REMEDIAR. These tablets will increase the stock of the program for this medicament.

It is important to remember that Paracetamol is one therapeutic option for the symptomatic treatment of dengue pathology.

REMEDIAR and LIF

Remediar Program is a national program that provides medicines to almost 7000 CAPS (Primary Health Centres) of Argentina.

From 2002 to 2011, the Remediar’s users were almost 15 million people.

During 2008 and 2009, LIF delivered four products to REMEDIAR:

In 2008, we delivered 10.171.560 drug units of one product: Cefalexin 500 mg. tablets. Medicine production grew 14% in comparison to 2007.

 In 2009, we delivered 50.000.000 drug units of four products: Cefalexin 250 mg  Powder for Oral Suspension; Cefalexin 500 mg; Amoxicillin 500 mg; Paracetamol 500 mg y Glibenclamida 5 mg. These last four products are tablets.

Public Production of Medicines’ Law

From June 2011, Argentina has a public production of medicines law.

This law was unanimously passed by the Argentine´s Senate. The research and public production of medicines, vaccines, medical device and drugs for production of medicines are declared of national interest. The law considers all these as common goods.

It proposes scientific and technology development through public laboratories.

Also, it promotes the research, the development and the production of orphan medicines.

The public laboratories can sign agreements with the universities to do quality control of medicines, vaccine and medical device.

LIF will produce Sildenafil

LIF is making research and development of Sildenafil syrup and tablets.

Syldenafil syrup is an orphan medicine used to treat Pulmonary Arterial Hypertension (PAH)* of the newborn. This is developed with the Rosario’s National University, School of Sciences Biochemical and Pharmaceutical.

On the other hand LIF is working on the development of Sildenafil tablets used to treat erectile dysfunction.

* PAH is a rare disease with an incidence of about 2-3 per million per year and a prevalence of about 15 per million. Adult females are almost three times as likely to present with PAH as adult males. The presentation of IPAH within children is more evenly split along gender lines. (N. Rudarakanchana, R C Trembath, N. W. Morrel. New insights into the pathogenesis and treatment of primary pulmonary hypertension)